Sign up to receive the UM Ventures e-newsletter, new technology announcements, and other news.
Prolias Technologies is an emerging molecular diagnostics company focusing on predictive
Countervail Corporation is focused on providing protection and treatment of military and
Profectus is a clinical-stage biotechnology company pioneering a major evolutionary step
A Health Informatics Company that was launched from the University of Maryland Baltimore/
Xcision creates site-specific stereotactic body radiotherapy (SBRT) solutions to treat
Oxyvita Inc. is a biotech company specializing in developing oxygen therapeutics and
Custom Spray Solutions is a technology start-up offering software products, measurement
React Labs is a new platform for real-time polling — a mobile app that lets users react
Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical
UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.